Virtual Art Therapy Assisted Re-Integration to Improve Biopsychosocial Outcomes in Adolescent and Young Adult Cancer Survivors, AVATARS Trial
NCT ID: NCT07089927
Last Updated: 2025-12-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
20 participants
INTERVENTIONAL
2025-07-02
2026-07-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
I. Investigate the AVATARS intervention's feasibility, usability, and acceptability among a sample of AYA cancer survivors.
II. Investigate the preliminary efficacy of the AVATARS intervention on biopsychosocial outcomes (i.e. anxiety, depression, resilience, emotional regulation, stress, and cognition) in AYA cancer survivors.
OUTLINE:
Patients complete virtual art therapy sessions, over 60 minutes, every 2 weeks, for 4 sessions. Patients then receive a 3D printed replica of their avatar.
After completion of study treatment, patients are followed up at 12, 24 and 36 weeks.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Supportive care (Virtual art therapy)
Patients complete virtual art therapy sessions, over 60 minutes, every 2 weeks, for 4 sessions. Patients then receive a 3D printed replica of their avatar.
Art Therapy
Complete virtual art therapy sessions. When complete the participant will receive a 3D printed replica of the avatar.
Interview
Ancillary studies
Survey Administration
Ancillary studies
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Art Therapy
Complete virtual art therapy sessions. When complete the participant will receive a 3D printed replica of the avatar.
Interview
Ancillary studies
Survey Administration
Ancillary studies
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Mild or greater depression \[Patient Health Questionnaire (PHQ-A) score \> 5\]
* Received a cancer diagnosis during the past year, or completed cancer treatment within the past five years (extended survivorship)
* Have access to an electronic device which supports Zoom videoconferencing (e.g., personal device or public library access)
* Able to read and write in English
Exclusion Criteria
* Visual or cognitive impairment which may impede completing the art project or the data collection measures
* Endorsed suicidality (via PHQ-A or otherwise)
18 Years
25 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mayo Clinic
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
C. Robert Bennett, PhD, RN
Role: PRINCIPAL_INVESTIGATOR
Mayo Clinic
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Mayo Clinic in Arizona
Scottsdale, Arizona, United States
Mayo Clinic in Rochester
Rochester, Minnesota, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Regina Becker
Role: primary
Regina Becker
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NCI-2025-04978
Identifier Type: REGISTRY
Identifier Source: secondary_id
24-012402
Identifier Type: OTHER
Identifier Source: secondary_id
AVATARS
Identifier Type: OTHER
Identifier Source: secondary_id
AVATARS
Identifier Type: -
Identifier Source: org_study_id